DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Oberthuer A, Warnat P, Kahlert Y, Westermann F, Spitz R, Brors B, Hero B, Eils R, Schwab M, Berthold F, Fischer M.
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.
Cancer Lett 2007; 250: 250-267
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.